Finance

Lists
JUBLPHARMA:NSE
Jubilant Pharmova Ltd
₹865.00
-0.35%
(-3.00) 1D
Aug 20, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JUBLPHARMA...
Open
₹871.00
High
₹886.35
Low
₹863.85
Mkt. cap
138.70B
Avg. vol.
0.00
Volume
181.30K
Dividend
0.58%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
39.01
52-wk high
₹1,184.80
52-wk low
₹786.05
EPS
₹22.17
No. of employees
6K
Open
₹871.00
High
₹886.35
Low
₹863.85
Mkt. cap
138.70B
Avg. vol.
0.00
Volume
181.30K
Dividend
0.58%
Quarterly dividend
₹1.25
Ex-dividend date
Jul 24, 2026
P/E ratio
39.01
52-wk high
₹1,184.80
52-wk low
₹786.05
EPS
₹22.17
No. of employees
6K
About Jubilant Pharmova Ltd
CEO-
Employees5.66K
Founded1978
HeadquartersNoida, Uttar Pradesh, India
SectorPharmaceutical industry
Websitejubilantpharmova.com
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹3.56 / ₹5.80
-38.62%miss
Revenue / Est. (INR)
22.29B / 22.62B
-1.44%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.66B
21.22B
22.90B
22.29B
Cost of goods sold
5.96B
7.16B
9.53B
7.49B
Cost of revenue
5.96B
7.16B
9.53B
7.49B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.36B
7.06B
8.34B
7.54B
Operating expense
11.33B
12.37B
11.14B
13.60B
Total operating expenses
17.30B
19.54B
20.68B
21.09B
Operating income
2.37B
1.69B
2.22B
1.21B
Other non operating income
98.00M
205.00M
-369.00M
199.00M
EBT including unusual items
1.90B
934.00M
1.76B
864.00M
EBT excluding unusual items
1.96B
1.33B
1.87B
864.00M
Income tax expense
704.00M
376.00M
567.00M
300.00M
Effective tax rate
36.99%
40.26%
32.22%
34.72%
Other operating expenses
3.92B
4.10B
1.63B
4.79B
Net income
1.20B
559.00M
1.19B
565.00M
Net profit margin
6.12%
2.63%
5.21%
2.53%
Earnings per share
7.85
5.01
8.10
3.56
Interest and investment income
-
-
252.00M
-
Interest expense
-502.00M
-561.00M
-461.00M
-542.00M
Net interest expenses
-502.00M
-561.00M
-209.00M
-542.00M
Depreciation and amortization charges
1.05B
1.21B
1.17B
1.27B
EBITDA
3.38B
2.30B
2.98B
1.96B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps